1 Siegel RL,Miller KD,Jemal A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34. 2 Zeng C,Matsuda K,Jia WH,et al.Identification of susceptibility loci and genes for colorectal cancer risk[J].Gastroenterology,2016,150(7):1633-1645. 3 Hartmann C,Schwietzer YA,Kummer D,et al.The mitochondrial outer membrane protein SYNJ2BP interacts with the cell adhesion molecule TMIGD1 and can recruit it to mitochondria[J].BMC Mol Cell Biol,2020,21(1):30. 4 Meyer RD,Zou X,Ali M,et al.TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer[J].Oncotarget,2017,9(11):9672-9684. 5 Cattaneo E,Laczko E,Buffoli F,et al.Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology(polypoid vs.nonpolypoid)[J].EMBO Mol Med,2011,3(6):334-347. 6 贺赛,孙学军,郑见宝,等.抑癌基因RASSF1A在结肠癌中的表达研究[J].中国普外基础与临床杂志,2013,20(11):1240-1244. 7 Kuipers EJ,Rösch T,Bretthauer M.Colorectal cancer screening--optimizing current strategies and new directions[J].Nat Rev Clin Oncol,2013,10(3):130-142. 8 孙燕,顾晋,汪建平.中国结直肠癌诊疗规范(2017年版)[J].上海医学,2018,41(8):449-463. 9 Flavahan WA,Gaskell E,Bernstein BE.Epigenetic plasticity and the hallmarks of cancer[J].Science,2017,357(6348):eaal2380. 10 邹雪青.关于包含免疫球蛋白结构域的跨膜蛋白1的抑癌因子作用及其机制的研究[D].济南:山东大学,2018. 11 Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation[J].Cell,2011,144(5):646-674. 12 Lee JM,Dedhar S,Kalluri R,et al.The epithelial-mesenchymal transition:new insights in signaling,development,and disease[J].J Cell Biol,2006,172(7):973-981. 13 Vaquero J,Guedj N,Clapéron A,et al.Epithelial-mesenchymal transition in cholangiocarcinoma:From clinical evidence to regulatory networks[J].J Hepatol,2017,66(2):424-441. |